IRIS
MONTOMOLI, EMANUELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.404
NA - Nord America 10.186
AS - Asia 1.714
AF - Africa 62
SA - Sud America 16
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 23.400
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.138
GB - Regno Unito 4.827
IE - Irlanda 1.754
IT - Italia 1.144
CN - Cina 987
UA - Ucraina 811
RU - Federazione Russa 756
SE - Svezia 753
FR - Francia 475
DE - Germania 413
SG - Singapore 411
FI - Finlandia 273
VN - Vietnam 192
CI - Costa d'Avorio 46
ES - Italia 38
BE - Belgio 37
CA - Canada 37
NL - Olanda 24
TR - Turchia 22
IN - India 20
KR - Corea 19
CZ - Repubblica Ceca 17
AU - Australia 11
AT - Austria 10
HK - Hong Kong 8
BR - Brasile 7
IR - Iran 7
JP - Giappone 7
LT - Lituania 7
PL - Polonia 7
BG - Bulgaria 6
CH - Svizzera 5
DK - Danimarca 5
GR - Grecia 5
LU - Lussemburgo 5
MX - Messico 5
AM - Armenia 4
EU - Europa 4
HU - Ungheria 4
KG - Kirghizistan 4
MA - Marocco 4
NG - Nigeria 4
PH - Filippine 4
RO - Romania 4
AR - Argentina 3
EG - Egitto 3
ID - Indonesia 3
IL - Israele 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PE - Perù 3
TW - Taiwan 3
ZA - Sudafrica 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
BY - Bielorussia 2
CY - Cipro 2
EE - Estonia 2
HR - Croazia 2
JM - Giamaica 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PK - Pakistan 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SC - Seychelles 2
AE - Emirati Arabi Uniti 1
CL - Cile 1
CO - Colombia 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
GL - Groenlandia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
ME - Montenegro 1
MK - Macedonia 1
OM - Oman 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TJ - Tagikistan 1
TM - Turkmenistan 1
Totale 23.400
Salva come PNG Salva come JPEG
Città #
Southend 4.623
Dublin 1.738
Fairfield 1.471
Chandler 987
Santa Clara 769
Ashburn 753
Woodbridge 710
Jacksonville 681
Houston 590
Wilmington 566
Seattle 552
Cambridge 470
Siena 425
Ann Arbor 406
Singapore 312
Princeton 282
Nanjing 229
Dong Ket 189
Beijing 172
San Mateo 118
Helsinki 114
San Diego 113
Boardman 112
Moscow 74
Nanchang 74
Florence 52
Shanghai 52
Shenyang 52
Munich 50
Tianjin 47
Abidjan 46
Rome 45
Lappeenranta 44
Hebei 42
Milan 37
Málaga 37
Brussels 36
London 35
Kunming 34
Jiaxing 32
New York 30
Norwalk 28
Changsha 26
Jinan 26
Dearborn 25
Hangzhou 25
Toronto 23
Redwood City 20
Los Angeles 18
Phoenix 18
Lancaster 17
Ningbo 17
Genova 16
Guangzhou 16
San Francisco 15
Zhengzhou 15
Fremont 14
Brno 13
Livorno 13
Taizhou 13
Frankfurt am Main 11
Izmir 11
Fuzhou 10
Auburn Hills 9
Vienna 9
Bari 8
Changchun 8
Chicago 8
Düsseldorf 8
Roccagorga 8
Amsterdam 7
Bologna 7
Dessau 7
Lanzhou 7
Paris 7
Washington 7
Alba 6
Hounslow 6
Kilburn 6
Melbourne 6
Mestre 6
Newark 6
Parma 6
Philadelphia 6
Stockholm 6
Torre Del Greco 6
Agliana 5
Clifton 5
Dallas 5
Hong Kong 5
Luxembourg 5
Monteriggioni 5
Mumbai 5
Naples 5
Ottawa 5
Pisa 5
Prescot 5
Renton 5
Venezia 5
Abuja 4
Totale 17.820
Salva come PNG Salva come JPEG
Nome #
A Phase III randomised trial of the immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses 502
Epidemiology of herpes simplex virus type 1 and 2 in Italy: a seroprevalence study from 2000 to 2014 473
How to assess the effectiveness of nasal influenza vaccines? Role and measurement of sIgA in mucosal secretions 462
Single dose vaccination of the ASO3-adjuvanted A (H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains 435
Toxoplasma gondii in women of childbearing age and during pregnancy: seroprevalence study in Central and Southern Italy from 2013 to 2017 407
Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy 399
2015/16 seasonal vaccine effectiveness against hospitalisation with influenza a(H1N1)pdm09 and B among elderly people in Europe: Results from the I-MOVE+ project 386
Pertussis over two decades: Seroepidemiological study in a large population of the Siena Province, Tuscany Region, Central Italy 356
Adjuvant is necessary for a robust immune response to a single dose of H1N1 pandemic flu vaccine in mice 228
Egg-Independent Influenza Vaccines and Vaccine Candidates 223
Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2 217
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients 206
Immunogenicity, safety and tolerability of inactivated trivalent influenza vaccine in overweight and obese children 194
Flucelvax (Optaflu) for seasonal influenza 192
Moderate vaccine effectiveness against severe acute respiratory infection caused by a(H1N1)pdm09 influenza virus and no effectiveness against a(H3N2) influenza virus in the 2018/2019 season in Italy 190
Influenza anti-stalk antibodies: Development of a new method for the evaluation of the immune responses to universal vaccine 190
Influenza immunology evaluation and correlates of protection: a focus on vaccines 189
A method for detection of neuraminidase antibody in serum 178
Comparative analysis of influenza A(H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination 178
Effectiveness of the trivalent MF59 adjuvated influenza vaccine in preventing hospitalization due to influenza B and A(H1N1)pdm09 viruses in the elderly in Italy, 2017 - 2018 season 177
Emerging influenza strains in the last two decades: A threat of a new pandemic? 176
Maraviroc as a potential HIV-1 latency-reversing agent in cell line models and ex vivo CD4 T cells 174
Influenza D virus: Serological evidence in the Italian population from 2005 to 2017 169
Challenges in the development of egg-independent vaccines for influenza 161
Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention 161
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: Awareness warranted for 2017/18 season 159
Comparison of hemagglutination inhibition, single radial hemolysis, virus neutralization assays, and ELISA to detect antibody levels against seasonal influenza viruses 157
Cell culture-derived influenza vaccines from Vero cells: a new horizon for vaccine production 156
Early rise of blood T follicular helper cell subsets and baseline immunity as predictors of persisting late functional antibody responses to vaccination in humans 154
Neisseria meningitidis infection: Who, when and where? 154
Retrospective Study Evaluating Seroprevalence of Hepatitis E Virus in Blood Donors and in Swine Veterinarians in Italy (2004) 153
Egg- or cell culture-derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines 151
Immunogenicity and safety of the new inactivated quadrivalent influenza vaccine vaxigrip tetra: Preliminary results in children ≥6 months and older adults 151
How much ozone bactericidal activity is compromised by plasma components? 150
Impact of erythrocyte species on assays for influenza serology 150
A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine 149
Influenza vaccines: Evaluation of the safety profile 149
Preclinical and clinical development of plant-made virus-like particle vaccine against avian H5N1 influenza 148
Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies 148
Age and influenza-specific pre-vaccination antibodies strongly affect influenza vaccine responses in the icelandic population whereas disease and medication have small effects 147
A new European perspective of influenza pandemic planning with a particular focus on the role of mammalian cell culture vaccines 145
Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice 145
N. meningitidis and TLR polymorphisms: A fascinating immunomodulatory network 145
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies 141
Swine influenza and vaccines: an alternative approach for decision making about pandemic prevention 141
RT-PCR multiplex per l’identificazione simultanea di influenza virus A/H1N1 A/H3N2 e B e Virus Respiratorio Sinciziale di tipo A e B 139
Pseudoparticle neutralization is a reliable assay to measure immunity and cross-reactivity to H5N1 influenza viruses 139
An unwanted guest: Neisseria meningitidis–carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence 138
Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge 138
Fighting Neisseria meningitidis: past and current vaccination strategies 137
A clinical trial of a whole-virus H5N1 vaccine derived from cell culture 137
null 136
Live attenuated influenza vaccine in children induces b-cell responses in tonsils 135
Recombinant Haemagglutinin Derived From the Ciliated Protozoan Tetrahymena thermophila Is Protective Against Influenza Infection 135
System-oriented optimization of multi-target 2,6-diaminopurine derivatives: Easily accessible broad-spectrum antivirals active against flaviviruses, influenza virus and SARS-CoV-2 134
Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates 134
A Heterologous MF59-Adjuvanted H5N1 Prepandemic Influenza Booster Vaccine Induces a Robust, Cross-Reactive Immune Response in Adults and the Elderly. 133
A Cell Culture (Vero)–Derived H5N1 Whole-Virus Vaccine Induces Cross-Reactive Memory Responses 132
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 132
null 130
Measles in pregnancy: a threat for Italian women? 130
International laboratory comparison of influenza microneutralization assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) influenza viruses by CONSISE 129
Prevalence of antibodies to Vaccinia virus after smallpox vaccination in Italy 128
Immunogenicity and safety of MF59-adjuvanted H5N1 influenza vaccine from infancy to adolescence 127
Susceptibility to varicella in childbearing age women, Central Italy: is there a need for vaccinating this population group? 127
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study 127
Is influenza A/H10N8 a potential candidate for the next pandemic? 127
Repeated seasonal influenza vaccination among elderly in Europe: Effects on laboratory confirmed hospitalised influenza 127
Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania 127
Cross-reactive antibody responses to the 2009 A/H1N1v influenza virus in the Italian population in the pre-pandemic period 125
Validation of Single Radial Haemolysis assay: A reliable method to measure antibodies against influenza viruses 125
Mapping host-related correlates of influenza vaccine-induced immune response: An umbrella review of the available systematic reviews and meta-analyses 125
Discordant correlation between serological assays observed when measuring heterosubtypic responses against avian influenza H5 and H7 viruses in unexposed individuals 125
Cost-benefit evaluation of anti-influenza vaccination in the elderly during two influenza seasons in the Siena district [Valutazione benefici-costi della vaccinazione antinfluenzale negli anziani in due stagioni epidemiche a confronto nella provincia di Siena] 125
Tick-borne encephalitis: the impact of epidemiology, changing lifestyle, and environmental factors. Conference report of the 12th Annual Meeting of the International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE) 123
Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine 123
Overview of serological techniques for influenza vaccine evaluation: Past, Present and Future 123
The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants 122
Difference in immune response in vaccinated and unvaccinated Swedish individuals after the 2009 influenza pandemic 121
Priming for Pandemic Influenza: Antigen-sparing MF59™-adjuvanted A/H5N1 Vaccine Induces Immunological Memory and Shows Cross-Reactive Potential in Adults Including the Elderly 121
Understanding the dynamics of seasonal influenza in Italy: incidence, transmissibility and population susceptibility in a 9-year period 120
Surveillance for severe acute respiratory infections among hospitalized subjects from 2015/2016 to 2019/2020 seasons in Tuscany, Italy 120
Safety, tolerability and immunogenicity of a mammalian cell culture-derived influenza vaccine: a sequential Phase I and Phase II clinical trial 118
Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations 117
Epidemiologia e prevenzione delle malattie dentali a Siena: studio pluriennale (1988-1996) su campioni di alunni della scuola dell'obbligo. 116
Correlates of protection against influenza 116
Evaluation of SARS‐CoV‐2 neutralizing antibodies using a CPE‐based colorimetric live virus micro‐neutralization assay in human serum samples 115
Impact of routine infant and adolescent hepatitis B vaccination in Tuscany, Central Italy 114
Expression of sialic acid influenza receptors in red blood cells from avian and mammalian species: an immunological comparative study 114
Pre-emptive vaccination against pandemic influenza virus 113
Immunity to measles in Italian children and adolescents: a persistent problem in view of measles elimination 113
Cross subclade immunity after one-year booster immunization with MF59®-adjuvanted A/H5N1 influenza vaccine in 6 month to 17 year-old children 112
Vaccination against Hepatitis B - Lenght of protection among populations at risk 109
Current adjuvants and new perspectives in vaccine formulation 109
Serologically-Based Evaluation of Cross-Protection Antibody Responses among Different A(H1N1) Influenza Strains 109
Low prevalence of antibodies against pertussis in pregnant women in Italy 108
null 108
CORRELATES OF PROTECTION AND HOST-RELATED MODIFIERS OF THE IMMUNOGENICITY OF INFLUENZA VACCINES: EVIDENCE MAPS AND EVIDENCE GAPS 107
The sporicidal effects of a biodegradable peroxidic disinfectant 106
Correlates of protection against influenza 106
Totale 16.402
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.107
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.107
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.869 0 0 0 0 0 388 376 593 422 438 260 392
2020/20214.814 238 431 214 578 376 503 220 565 369 530 359 431
2021/20222.653 236 394 263 233 100 75 115 174 164 214 225 460
2022/20233.333 201 296 402 480 311 666 90 299 344 62 111 71
2023/20242.547 86 75 187 110 101 589 981 75 27 111 38 167
2024/20252.646 160 386 611 352 727 410 0 0 0 0 0 0
Totale 23.891